Renaissance Investment Group Has Cut Cvs Health (CVS) Holding, Westpac Banking (ADR) (WBK) Had 2 Analysts Last Week

May 29, 2017 - By Kurt Siggers

Among 3 analysts covering Westpac Banking (NYSE:WBK), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Westpac Banking had 3 analyst reports since September 2, 2015 according to SRatingsIntel. The rating was upgraded by Macquarie Research to “Outperform” on Tuesday, May 24. Credit Suisse upgraded the stock to “Outperform” rating in Wednesday, September 2 report. JP Morgan downgraded Westpac Banking Corp (ADR) (NYSE:WBK) on Thursday, August 11 to “Neutral” rating. See Westpac Banking Corp (ADR) (NYSE:WBK) latest ratings:

Renaissance Investment Group Llc decreased Cvs Health Corp (CVS) stake by 10.47% reported in 2016Q4 SEC filing. Renaissance Investment Group Llc sold 4,133 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Renaissance Investment Group Llc holds 35,360 shares with $2.79 million value, down from 39,493 last quarter. Cvs Health Corp now has $78.79 billion valuation. The stock increased 0.91% or $0.69 on May 26, reaching $76.64. About 3.61 million shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since May 29, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

The stock decreased 0.57% or $0.13 on May 26, reaching $22.78. About 312,479 shares traded or 35.08% up from the average. Westpac Banking Corp (ADR) (NYSE:WBK) has risen 6.51% since May 29, 2016 and is uptrending. It has underperformed by 10.19% the S&P500.

Westpac Banking Corporation is a banking organization. The company has market cap of $75.60 billion. The Firm provides a range of banking and financial services in markets, including consumer, business and institutional banking and wealth management services. It has a 13.77 P/E ratio. The Firm is engaged in the provision of financial services, including lending, deposit taking, payments services, investment portfolio management and advice, superannuation and funds management, insurance services, leasing finance, general finance, interest rate risk management and foreign exchange services.

Among 17 analysts covering CVS Health (NYSE:CVS), 10 have Buy rating, 0 Sell and 7 Hold. Therefore 59% are positive. CVS Health had 27 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was downgraded by Goldman Sachs on Thursday, December 17 to “Neutral”. As per Thursday, May 12, the company rating was maintained by Jefferies. The rating was initiated by UBS with “Buy” on Thursday, October 6. The rating was maintained by JP Morgan on Monday, November 2 with “Overweight”. The stock of CVS Health Corp (NYSE:CVS) has “Neutral” rating given on Monday, February 6 by Atlantic Securities. The firm has “Buy” rating by Tigress Financial given on Friday, April 28. As per Monday, June 20, the company rating was downgraded by Morgan Stanley. Jefferies downgraded the stock to “Hold” rating in Monday, December 12 report. On Monday, November 2 the stock rating was maintained by S&P Research with “Strong Buy”. The rating was maintained by Oppenheimer on Monday, November 2 with “Outperform”.

Investors sentiment decreased to 0.74 in Q4 2016. Its down 0.24, from 0.98 in 2016Q3. It worsened, as 135 investors sold CVS shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Hall Laurie J Trustee stated it has 8,886 shares. First Manhattan Communications has 2.65 million shares. The Massachusetts-based Ngam Limited Partnership has invested 0.21% in CVS Health Corp (NYSE:CVS). Sawgrass Asset Mgmt Lc has 0.08% invested in CVS Health Corp (NYSE:CVS). 40,470 are owned by Wellington Shields Mgmt Lc. Levin Capital Strategies Ltd Partnership holds 523,796 shares. Regentatlantic Cap Ltd Llc accumulated 153,110 shares or 1.18% of the stock. Japan-based Sumitomo Mitsui Trust has invested 0.39% in CVS Health Corp (NYSE:CVS). Pggm Invs accumulated 1.05M shares. Webster Natl Bank N A reported 78,357 shares. Bancorporation Of The Ozarks holds 0.45% of its portfolio in CVS Health Corp (NYSE:CVS) for 17,578 shares. 35,781 were accumulated by Liberty Cap. Dana Investment Advisors owns 68,355 shares or 0.25% of their US portfolio. Washington Tru National Bank & Trust accumulated 6,565 shares. Texas Permanent School Fund reported 319,465 shares.

Since February 1, 2017, it had 0 insider buys, and 6 selling transactions for $22.09 million activity. Denton David M had sold 95,618 shares worth $7.71 million on Friday, March 10. 76,494 CVS Health Corp (NYSE:CVS) shares with value of $5.99 million were sold by MERLO LARRY J. Shares for $4.90M were sold by Roberts Jonathan C. Another trade for 14,104 shares valued at $1.13M was made by Sussman Andrew on Monday, March 13. Brennan Troyen A also sold $1.88M worth of CVS Health Corp (NYSE:CVS) on Tuesday, March 21. $479,908 worth of CVS Health Corp (NYSE:CVS) was sold by Boratto Eva C on Friday, March 17.

Analysts await CVS Health Corp (NYSE:CVS) to report earnings on August, 1. They expect $1.31 EPS, down 0.76% or $0.01 from last year’s $1.32 per share. CVS’s profit will be $1.35B for 14.63 P/E if the $1.31 EPS becomes a reality. After $1.17 actual EPS reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 11.97% EPS growth.